(kÄn'sÉr) 1  A disease characterized by any of various malignant neoplasms composed of abnormal cells that tend to proliferate rapidly and invade surrounding tissue. Without treatment such as chemotherapy or radiation, cancer cells can metastasize to other body sites and cause organ failure and death. 2  A malignant tumor.
Dosage and Administration (2.6, 2.7) 8/2016. Warnings and Precautions (5.10) 8/2016. INDICATIONS AND USAGE Gleevec is a kinase inhibitor indicated for the treatment of: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (1.1)
â¢83037: Hemoglobin; glycosylated (A1C) by device cleared by FDA for home use.[5]. A1CNow+ is approved for use with either a capillary or venous blood specimen. Note 1: CPT code 83037 may be billed when an A1C test is performed in a providerâs office using a device cleared by the FDA for home use. CPT code 83037 is not intended to report an A1C test result that is obtained in a patientâs home by the patient or family.[6]. Note 2: The QW modifier should be used when coding for Medicare and Medicaid beneficiaries.